Comparison

Torkinib (PP242) European Partner

€68.00
Excl. VAT
Item no. S2218-5
Manufacturer Selleckchem
CASRN 1092351-67-1
Amount 5 mg
Category
Type Inhibitors
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias TORKinib
Similar products PP242
Available
Administration
Oral gavage
Animal Models
Syngeneic (Balbc/J) mice with mouse p190-transformed BM cells to initiate leukemia, and female NSG mice injected (i.v.) with SUP-B15ffLuc cells or human Ph+ leukemia
Cell lines
MEFs
Chemical Name
2-(4-amino-1-isopropyl-1H-pyrazolo[3, 4-d]pyrimidin-3-yl)-1H-indol-5-ol
Concentrations
Dissolved in DMSO, final concentrations ca.10 uM
Description
PP242 is a selective mTOR inhibitor with IC50 of 8 nM.
Dosages
ca.60 mg/kg/day
Features
PP242 is a first selective inhibitor that targets ATP domain of mTOR.
Formulation
Dissolved in PEG400 (Carbowax polyethylene glycol)
IC50
8 nM [1], 8 nM [1], 8 nM [1], 8 nM [1], 8 nM [1], 8 nM [1]
In vitro
PP242 exhibits potent selectivity for mTOR over other PI3K family kinases such as p110alpha, p110beta, p110gamma, p110delta, and DNA-PK with IC50 of 1.96 uM, 2.2 uM, 1.27 uM, 0.102 uM, and 0.408 uM, respectively. PP242 displays some inhibitory activity against Ret, PKCalpha, PKCbeta, and JAK2, while exhibits remarkable selectivity against 215 other protein kinases. Unlike rapamycin, PP242 inhibits both mTORC1 and mTORC2. In BT549 cells, PP242 treatment (0.04-10 uM) inhibits the phosphorylation of Akt, the mTOR substrate p70S6K, and its downstream target S6 in a dose-dependent manner. [1] PP242 potently inhibits PKCalpha with IC50 of 49 nM. Low concentrations of PP242 inhibit the phosphorylation of Akt S473 and higher concentrations partially inhibit Akt T308-P in addition to S473-P. As PP242 is a more effective mTORC1 inhibitor than rapamycin, PP242 inhibits the proliferation of primary MEFs, and the phosphorylation of 4EBP1 at T36/45 and S65, more potently than rapamycin. PP242 but not rapamycin potently inhibits cap-dependent translation, by causing a higher level of binding between 4EBP1 and eIF4E than rapamycin. [2] PP242 potently inhibits the proliferation of p190-transformed murine BM, SUP-B15, and K562 cells with GI50 of 12 nM, 90 nM, and 85 nM, respectively. PP242 also inhibits the growth of solid tumor cell lines such as SKOV3, PC3, 786-O, and U87 with GI50 of 0.49 uM, 0.19 uM, 2.13 uM, and 1.57 uM, respectively. [3] PP242 is also more effective than rapamycin in achieving cytoreduction and apoptosis in multiple myeloma (MM) cells. [4]
In vivo
Administration of PP242 is able to completely inhibit the phosphorylation of Akt at S473 and T308 in fat and liver of mice. PP242 only partially inhibits the phosphorylation of Akt in skeletal muscle and is more effective at inhibiting the phosphorylation of T308 than S473, despite able to fully inhibit the phosphorylation of 4EBP1 and S6. [2] Oral administration PP242 potently delays the leukemia onset in the mice model, and induces leukemia regression by inhibiting mTORC2 and mTORC1 activation that correlates with loss in cell size. [3] PP242 treatment potently inhibits the growth of 8226 cells in mice. [4]
Incubation Time
72 hours
Kinase Assay
In vitro mTOR (FRAP1) kinase assay, Recombinant mTOR is incubated with PP242 at 2-fold dilutions over a concentration range of 50-0.001 uM in an assay containing 50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween, 10 uM ATP (2.5 uCi of gamma-32P-ATP), and 3 ug/mL BSA. Rat recombinant PHAS-1/4EBP1 (2 mg/mL) is used as a substrate. Reactions are terminated by spotting onto nitrocellulose, which is washed with 1 M NaCl/1% phosphoric acid (approximately 6 times, 5-10 minutes each). Sheets are dried and the transferred radioactivity quantitated by phosphorimaging. IC50 value is calculated by fitting the data to a sigmoidal dose-response curve using the Prism software package.
Method
Cells are treated with increasing concentrations of PP242 for 72 hours in 96-well plates. After 72 hours of treatment, 10 uL of 440 uM resazurin sodium salt is added to each well, and after 18 hours, the florescence intensity in each well is measured using a top-reading florescent plate reader with excitation at 530 nm and emission at 590 nm.
Molecular Weight (MW)
308, 34
Picture ChemicalStructure Description
PP242 Chemical Structure
Picture Description 1
, , Dr. Zhang, of Tianjin Medical University, PP242purchased from Selleck, A549 cells were pretreated with 100ng/ml EGF for 20 min and then treated with the indicated concentrations of PP242 for 24 hours.
Solubility (25C)
DMSO 62 mg/mL, Water <1 mg/mL, Ethanol 18 mg/mL
Storage
2 years -20CPowder, 2 weeks4Cin DMSO, 2 months-80Cin DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €68.00
Price: €68.00
available

Delivery expected until 8/28/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close